Castuner

Pearl Meyer Unscripted

Pearl Meyer

Pearl Meyer Unscripted dives into the real-world challenges and conversations shaping executive compensation and leadership strategy. Forthright, insightful, and sometimes unexpected—this is where we connect the dots between people, purpose, and performance.

Strona podcastu

Słuchaj w swojej aplikacji

Odcinki

37 odcinków

  1. S4E14: The Current State of Bank Incentives: A Board-Level View 15:46
  2. S4E13: Incentive Metrics That Matter: Balancing Mission, Financial Sustainability, and Performance 14:39
  3. S4E12: Retention, Performance, and Mission: Long-Term Incentives in Tax-Exempt Organizations 13:05
  4. S4E11: Tax-Exempt Healthcare and the Executive Pay Gap: How Boards Can Compete 17:25
  5. S5E5: Beyond the Transaction: Is Your Leadership Team Ready for What Comes Next? 14:37
  6. S5E4: Are Stock Options Back? Rethinking Long-Term Incentive Design 17:27
  7. S5E3: Lower Disclosure, Higher Stakes? Rethinking Executive Compensation Communications 16:29
  8. S5E2: Who’s Next Isn’t Enough: Closing the Succession Readiness Gap 19:06
  9. S5E1: When Strategy Changes, Should Incentives Change Too? 16:12
  10. S4E10: Is Equity Still Earning Its Keep? Stock-Based Compensation in Technology 13:39
  11. S4E9: Riding the AI Infrastructure Wave: Executive Compensation and Durable Value Creation 13:20
  12. S4E8: Technology Compensation After the AI Boom: Why One Strategy No Longer Fits All 14:05
  13. S4E7: From Growth Story to AI Value Creation: Executive Compensation in Technology 15:11
  14. S4E6: New Growth, New Metrics: Rethinking Oil & Gas Compensation When Strategy Changes 14:14
  15. S4E5: Avoiding Feast or Famine: Designing Incentive Plans in Oil & Gas 14:18
  16. S4E4: When the Peer Group Shrinks: Executive Compensation in Oil & Gas 15:00
  17. S4E3: The Life Sciences IPO Playbook: Key Compensation Decisions Before Going Public 14:26
  18. S4E2: Burn Rate, Dilution, and the Fight for Life Sciences Talent 15:31
  19. S4E1: Pressure Testing Annual Incentive Programs for Emerging Growth Life Science Companies 12:39
  20. S3E6: The PE CFO Balancing Act: Play Maker and Game Manager 16:11
  21. S3E5: Human Capital Due Diligence as a PE Value Creation Lever 14:43
  22. S3E4: Culture as a Risk Factor, Not a Value Statement 15:30
  23. S3E3: Why Company Transformation Often Fails at the Human Level 16:12
  24. S3E2: Governing in Permanent Uncertainty 15:29
  25. S3E1: The Leadership Bench Problem No One Wants to Admit 14:26
  26. S2E6: The SEC’s Evolving Agenda and Looking Ahead to Proxy Season 17:12
  27. S2E5: How to Approach Discretion In Executive Compensation Programs 15:04
  28. S2E4: Do Metrics Based on ESG Objectives Belong in Incentive Plans? 16:06
  29. S2E3: Executive Succession and CEO Turnover 14:17
  30. S2E2: Performance-Based Equity Awards and Other LTI Trends 18:33
  31. S2E1: Board Governance Is Evolving – Is Your Compensation Committee Keeping Pace? 17:47
  32. S1E6: From Innovation to Accounting and Back Again 10:38
  33. S1E5: Creating Space for Non-Financial Metrics 14:19
  34. S1E4: Testing Assumptions: Do We Have the Right Metrics? 12:19
  35. S1E1: Is it Feeling Like Spring 2020? 13:29
  36. S1E3: The Near-Term Problem with Long-Term Forecasting 11:39
  37. S1E2: Management's Annual Incentive Plan Targets: Stretch Goals or Layups? 12:11